Rapid Dose Therapeutics Corp.
RDTCF
$0.15
$0.0436.36%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.92% | 56.20% | -18.48% | -23.52% | 12.94% |
| Total Depreciation and Amortization | 3.57% | 128.30% | 19.14% | -4.63% | -39.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.73% | -53.17% | 1.53% | 50.48% | -26.79% |
| Change in Net Operating Assets | 58.38% | -123.44% | 155.29% | 4.72% | 402.42% |
| Cash from Operations | 38.25% | -9,765.63% | 101.65% | -1.52% | 58.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 115.00% | -- | -- | -- |
| Total Debt Issued | 133.93% | -- | -- | -- | -52.40% |
| Total Debt Repaid | -- | -- | 81.80% | -140.10% | -243.64% |
| Issuance of Common Stock | -- | -- | -94.65% | 53.72% | -46.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -45.16% | 2,821.09% | -107.50% | 6.29% | -61.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -1,607.41% | -- | -- | -- | -- |
| Net Change in Cash | -225.27% | 372.59% | 41.30% | 23.84% | 14.20% |